Research status and recent advances of nanophthalmos
10.3760/cma.j.cn511434-20180824-00298
- VernacularTitle:真性小眼球研究现状与进展
- Author:
You TANG
1
;
Meixia ZHANG
Author Information
1. 四川大学华西医院，成都 610041
- From:
Chinese Journal of Ocular Fundus Diseases
2020;36(5):400-403
- CountryChina
- Language:Chinese
-
Abstract:
Nanophthalmos is a congenital disorder, which is characterized by small eye without any ocular or systemic malformation. It has autosomal-dominant and recessive forms of inheritance. It manifests as reduced total axial length, high hyperopia and thickened sclera. Nanophthalmos is relatively rare, but at high risk of secondary angle-closure glaucoma, uveal effusion syndrome. It can be spontaneous remission or recurrent, and responses poorly to medication. The effect of systemic glucocorticoid treatment is not ideal. The surgery challenges with very high rate of intra- and post-operative complications such as hemorrhage, choroidal and retinal detachment, malignum glaucoma and uveal effusion, so that the prognosis is poor. It is of great instructive significance to further understand the clinical features, complications and treatment progress and to avoid the missed diagnosis and misdiagnosisi of its complications, and thus choose the right management.
